19:11:33 EDT Mon 19 Oct 2026
Enter Symbol
or Name
USA
CA



EGF Theramed Health Corp (2)
Symbol TMED
Shares Issued 10,491,161
Close 2026-06-04 C$ 0.07
Market Cap C$ 734,381
Recent Sedar+ Documents

EGF appoints Da Costa as director, CEO, interim CFO

2026-10-19 17:17 ET - News Release

Mr. Connor Yuen reports

EGF THERAMED ANNOUNCES APPOINTMENT OF DA COSTA

EGF Theramed Health Corp. has appointed Kevin Da Costa to the board of directors and as chief executive officer and interim chief financial officer following the resignation of Connor Yuen as a director, chief executive officer and interim chief financial officer.

Mr. Da Costa is an entrepreneur with extensive experience in business development, digital commerce, technology integration and brand management, having founded and managed multiple ventures across consumer products, e-commerce, digital services and emerging technologies. As founder of Vesper Systems, he develops technology-driven business solutions that use artificial intelligence, automation and data-informed strategies to improve operational performance and uncover new growth opportunities. His hands-on experience and multidisciplinary approach position him to guide EGF Theramed Health through its next phase of corporate development as the company evaluates strategic opportunities, strengthens its operations, explores emerging technologies and pursues sustainable long-term value for shareholders.

The company would like to thank Mr. Yuen for his time spent on the company and wishes him well in his future endeavours.

About EGF Theramed Health Corp.

EGF is a consumer technology company engaged in the provision of biomedical on-line services for monitoring and treating common health problems. The company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations as well as medical monitoring device technology. The company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs (standard operating procedures).

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.